A randomized controlled study of (2″ R)-4'-O-tetrahydropyranyladriamycin and adriamycin in combination with cyclophosphamide and 5-fluorouracil in the treatment of advanced and recurrent breast cancer-Reference-Cited by-同舟云学术

A randomized controlled study of (2″ R)-4'-O-tetrahydropyranyladriamycin and adriamycin in combination with cyclophosphamide and 5-fluorouracil in the treatment of advanced and recurrent breast cancer

Published:1989-01 Issue:4 Volume:43 Page:271-278
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Tominaga T.,Abe O.,Enomoto K.,Abe R.,Iino Y.,Koyama H.,Fujimoto M.,Nomura Y.

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference18 articles.

1. Phase II study of (2″R)-4'-O-tetrahydropyranyladriamycin (THP) in breast cancer;Abe;Jpn. J. Cancer Chemother,1986

2. Response evaluation criteria for patients with advanced and recurrent breast cancer;Clinical Study Group for Breast Cancer in Japan;Jpn. J. Cancer Clin.,1982

3. Criteria for the evaluation of the clinical effects of solid cancer chemotherapy;Japan Society for Cancer Therapy;J. Jpn. Soc. Cancer Ther.,1986

4. Phase II study of 4'-O-tetrahydropyranyladriamycin (THP-ADM) in patients with gynaecological cancer;Kalo;Jpn. J. Cancer Chemother,1985

5. A phase II study of (2″R)-4'-O-tetrahydropyranyladriamycin (THP) in patients with hematological malignancies;Kimura;Jpn. J. Cancer Chemother.,1986

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Upregulated MELK Leads to Doxorubicin Chemoresistance and M2 Macrophage Polarization via the miR-34a/JAK2/STAT3 Pathway in Uterine Leiomyosarcoma;Frontiers in Oncology;2020-04-22

2. Adjuvant Therapy of Breast Cancer with Pirarubicin Versus Epirubicin in Combination with Cyclophosphamide and 5-fluorouracil;The Breast Journal;2011-09-20

3. Adjuvant Chemotherapy Including Cisplatin in Endometrial Carcinoma;Gynecologic and Obstetric Investigation;2000

4. Phase II study of pirarubicin combined with cisplatin in recurrent ovarian cancer;Journal of Cancer Research and Clinical Oncology;1994-03

5. Prospects for pirarubicin;Medical and Pediatric Oncology;1994